The report finds that investment into the European cannabis sector has reached an estimated €1.2 billion as of June 2021, with over 50% of publicly recorded deals flowing into healthcare segments and another 40% into wellness opportunities.
On 18 September 2020 the Financial Conduct Authority (FCA) published guidance on the listing of cannabis-based businesses onto public stock exchanges in the UK.
Government today has announced that it is changing importation restrictions regarding medicinal cannabis, so as to minimize the waiting time for fulfillment of prescriptions.
On September 21 2018, the U. K. Government announced that cannabis-based products for medicinal use would become available for specialist doctors to prescribe legally.